Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-06-06
1986-09-23
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548374, 548378, A61K 31415, C07D23112, C07D40506
Patent
active
046136100
ABSTRACT:
Compounds of the formula ##STR1## wherein R.sub.1 is C.sub.1-6 alkyl not containing an asymmetric carbon atom,
REFERENCES:
patent: 3983140 (1976-09-01), Endo et al.
patent: 4198425 (1980-04-01), Mitsui et al.
patent: 4248889 (1981-02-01), Oka et al.
patent: 4255444 (1981-03-01), Oka et al.
patent: 4308378 (1981-12-01), Stokker
patent: 4351844 (1982-09-01), Patchett et al.
patent: 4361515 (1982-11-01), Terahara et al.
patent: 4375475 (1983-03-01), Willard et al.
patent: 4376863 (1983-03-01), Lam
patent: 4387242 (1983-06-01), Lam
patent: 4440927 (1984-04-01), Prugh
patent: 4474971 (1984-10-01), Wareing
patent: 4503072 (1985-03-01), Hoffman et al.
Hulcher, Arch. Biochem. Biophys. 146, 422-427 (1971).
Sato et al., Chem. Pharm. Bull. 28, 1509-1525 (1980).
Singer et al., Proc. Soc. Exp. Biol. Med. 102, 370-373 (1959).
Briscoe Kurt G.
Kassenoff Melvyn M.
Sandoz Pharmaceuticals Corp.
Schwartz Richard A.
Sharkin Gerald D.
LandOfFree
Cholesterol biosynthesis inhibiting pyrazole analogs of mevalono does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cholesterol biosynthesis inhibiting pyrazole analogs of mevalono, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholesterol biosynthesis inhibiting pyrazole analogs of mevalono will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-766645